MedPath

TALIAZ LTD

🇮🇱Israel
Ownership
-
Employees
-
Market Cap
-
Website

Confirm the Effectiveness of Predictix Genetics Antidepressant -Guided Treatment in Adults With MDD

Not Applicable
Recruiting
Conditions
Major Depressive Disorder
Interventions
Device: Predictix Genetics Antidepressant
First Posted Date
2021-11-30
Last Posted Date
2021-11-30
Lead Sponsor
Taliaz Ltd.
Target Recruit Count
354
Registration Number
NCT05137197
Locations
🇫🇷

Hospital Pitié Salpétrière, Paris, France

🇨🇭

Hôpitaux Universitaires de Genève, Geneve, Switzerland

🇧🇪

Psy Pluriel, Liège, Belgium

Post Marketing Study for the Evaluation of Predictix Antidepressant Clinician Software Support Tool in Prescribing Antidepressant Medication/s for the Treatment of Patients Suffering From Major Depressive Disorder

Phase 4
Conditions
Major Depressive Disorder
Interventions
Device: Predictix Antidepressant Software tool
First Posted Date
2019-10-24
Last Posted Date
2019-10-24
Lead Sponsor
Taliaz Ltd.
Target Recruit Count
30
Registration Number
NCT04138290
Locations
🇫🇷

Hospital Pitié Salpétrière, Paris, France

Controlled Study to Evaluate the Safety and Efficacy of the Predictix Antidepressant Clinician Support Tool

Not Applicable
Conditions
Major Depressive Disorder
Interventions
Device: Predictix Antidepressant
First Posted Date
2019-07-24
Last Posted Date
2019-07-24
Lead Sponsor
Taliaz Ltd.
Target Recruit Count
220
Registration Number
NCT04031157
Locations
🇮🇱

Maccabi healthcare services, Tel Aviv, Israel

© Copyright 2025. All Rights Reserved by MedPath